FDA Approves Igalmi (Dexmedetomidine) Sublingual Film

Drug Info: ApoThera Drug Disease Clinical Support App

– Assess vital signs including orthostatic measurements before administering

Mild or Moderate Schizophrenia Agitation
– 120 mcg SL or BUC x 1 dose
– May give additional 60 mcg for up to 2 doses at least 2 hour apart
– Maximum Dose: 240 mcg/day

Severe Schizophrenia Agitation
– 180 mcg SL or BUC x 1 dose
– May give additional 90 mcg for up to 2 doses at least 2 hr apart
– Maximum Dose: 360 mcg/day

Mild to Moderate Bipolar Disorder Agitation
– 120 mcg SL or BUC x 1 dose
– May give additional 60 mcg for up to 2 doses at least 2 hr apart
– Maximum Dose: 240 mcg/day

Severe Bipolar Disorder Agitation
– 180 mcg SL or BUC x 1 dose
– May give additional 90 mcg for up to 2 doses at least 2 hr apart
– Maximum Dose: 360 mcg/day